Printer Friendly

AEQUITRON MEDICAL NAMES NEW DIRECTOR OF QUALITY ASSURANCE

 AEQUITRON MEDICAL NAMES NEW DIRECTOR OF QUALITY ASSURANCE
 MINNEAPOLIS, April 14 /PRNewswire/ -- Aequitron Medical, Inc. (NASDAQ-NMS: AQTN) announced today that it has named Wray A. Wentworth as director of quality assurance. Wentworth brings over 30 years of operations and quality assurance experience to Aequitron.
 Before joining Aequitron, Wentworth was general manager of the Plastics Division of Resistance Technology, Inc. He was responsible for establishing a new division at Resistance Technology -- an injection molding department with a manufacturing representative network. Additionally, he developed a product for the hearing aid market which has grown to 15 percent of the company's annual revenues. He also created employee-involved quality improvement programs which included both quality circles and manufacturing cells.
 Prior to serving as general manager, he was director of operations for Resistance Technology. While serving as director, the operations department eliminated the back orders and at the same time sales grew by more than 130 percent. He has also held key operations and quality assurance positions with Dahlberg Electronics, Stimtech Incorporated, Control Data and Honeywell.
 Wentworth received his bachelor of science degree in electrical engineering from the University of North Dakota. He also served on active military duty as a test and evaluation officer for the U.S. Navy.
 Curtis J. Olson, Aequitron president and CEO said, "Wray Wentworth has proven ability in quality assurance and operations management. His abilities will be integral to helping the company achieve its goals of diversifying product lines and enhancing revenues while maintaining Aequitron's high standards of product quality."
 Aequitron Medical, Inc. designs, manufactures and markets electronic products for home health care and hospital use; and wheelchair lifts and automobile hand controls for the mobility impaired. The company's common stock is traded on the National Market System under the NASDAQ symbol AQTN.
 -0- 4/14/92 R
 /CONTACT: David Neuger, (Home) 612-699-6730; or Ed Neuger, (Home) 612-929-0945, both of Edwin Neuger & Associates, 612-333-6621, for Aequitron Medical/
 (AQTN) CO: Aequitron Medical, Inc. ST: Minnesota IN: MTC SU: PER


KH -- MN099R -- 8842 04/15/92 15:30 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 15, 1992
Words:338
Previous Article:WHITMAN ANNOUNCES SALES AND EARNINGS
Next Article:AT&T CHAIRMAN IS ELECTED A DIRECTOR OF THE NEW YORK FED


Related Articles
AEQUITRON MEDICAL CHALLENGES CLASS ACTION SUIT INVOLVING APNEA MONITOR
AEQUITRON MEDICAL APPOINTS DIRECTORS OF SALES AND MARKETING
AEQUITRON MEDICAL ANNOUNCES MARKET RELEASE OF NEW GENERATION OXYGEN CONCENTRATOR
AEQUITRON MEDICAL NAMES NEW VICE PRESIDENT OF RESEARCH AND DEVELOPMENT
AEQUITRON MEDICAL NAMES NEW DIRECTOR OF QUALITY ASSURANCE
AEQUITRON MEDICAL NAMES FORMER BAXTER EXECUTIVE AS NEW PRESIDENT AND CEO
HICKEY NAMED TO AEQUITRON BOARD OF DIRECTORS
AEQUITRON MEDICAL ANNOUNCES AGREEMENT WITH ONE OF NATION'S LARGEST HOME HEALTH CARE PROVIDERS
AEQUITRON MEDICAL NAMES VICE PRESIDENT OF RESEARCH & DEVELOPMENT
AEQUITRON MEDICAL EARNS ISO 9001 CERTIFICATION

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters